Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Watchful Waiting × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 24 Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 13 Neoplasms 10 Colonic Neoplasms 9 Uterine Cervical Neoplasms 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Renal Cell 5 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Dysplasia 3 Thrombocythemia, Essential 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Papillomavirus Infections 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Gallbladder Neoplasms 3 Anus Neoplasms 3 Vulvar Neoplasms 2

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Melphalan 9 Cyclophosphamide 9 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 tebentafusp 6 Temozolomide 6 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 Blood Specimen Collection 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07338968 2026-01-14

CoMpass

Aura Biosciences

Not yet recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡